• <samp id="ossg8"></samp>
    <tbody id="ossg8"><nobr id="ossg8"></nobr></tbody>
    <menuitem id="ossg8"><strong id="ossg8"></strong></menuitem>
  • <samp id="ossg8"></samp>
    <menuitem id="ossg8"><strong id="ossg8"></strong></menuitem>
  • <menuitem id="ossg8"><ins id="ossg8"></ins></menuitem>

  • <tbody id="ossg8"><nobr id="ossg8"></nobr></tbody>
    <menuitem id="ossg8"></menuitem>
        Skip Navigation LinksSkip Navigation Links
        Centers for Disease Control and Prevention
        Safer Healthier People
        Blue White
        Blue White
        bottom curve
        CDC Home Search Health Topics A-Z spacer spacer
        spacer
        Blue curve MMWR spacer
        spacer
        spacer


         

        Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

        Appendix F

        Abbreviations used in this report
         

        ACIP Advisory Committee on Immunization Practices
        ap acellular pertussis vaccine (without tetanus and diphtheria toxoids)
        B. bronchiseptica Bordetella bronchiseptica
        B. holmesii Bordetella holmesii
        B. parapertussis Bordetella parapertussis
        B. pertussis Bordetella pertussis
        C. diphtheriae Corynebacterium diphtheriae
        C. tetani Clostridium tetani
        C. ulcerans Corynebacterium ulcerans
        CI confidence interval
        CSTE Council of State and Territorial Epidemiologists
        DFA direct fluorescent antibody
        DT pediatric diphtheria and tetanus toxoids vaccine
        DTaP pediatric diphtheria and tetanus toxoids and acellular pertussis vaccine
        DTP pediatric diphtheria and tetanus toxoids and whole cell pertussis vaccine
        EU ELISA units
        ELISA enzyme-linked immunosorbent assay
        ELS extensive limb swelling
        FDA Food and Drug Administration
        FHA filamentous hemagglutinin
        FIM fimbriae
        GMC geometric mean antibody concentration
        GMT geometric mean titer
        GSK GlaxoSmithKline Biologicals
        HAI haemagglutinin inhibition
        HIV human immunodeficiency virus
        IM intramuscularly
        IOM Institute of Medicine
        IU international units
        Lf limit of flocculation unit
        MCV4 tetravalent meningococcal conjugate vaccine
        MDPH Massachusetts Department of Public Health
        mIU milli-international unit
        mL milliliter
        MPHBL Massachusetts Public Health Biologic Laboratories
        ng nanogram
        NNDSS National Notifiable Diseases Surveillance System
        NHANES National Health and Nutritional Examination Survey
        PCR  polymerase chain reaction
        2-PE 2-phenoxyethanol
        PRN pertactin
        PPD tuberculin purified protein derivative
        PT pertussis toxin
        QALY quality adjusted life year
        SAE serious adverse event
        sp sanofi pasteur
        SPSS Supplemental Pertussis Surveillance System
        Tdap tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine
        Td adult tetanus and diphtheria toxoids vaccine
        TIG tetanus immune globulin
        TIV  trivalent inactivated influenza vaccine
        TT tetanus toxoid vaccine
        VAERS Vaccine Adverse Event Reporting System
        VICP Vaccine Injury Compensation Program
        µg microgram

         

        Advisory Committee on Immunization Practices Pertussis Working Group

        Chair: Jon Abramson, MD, Winston-Salem, North Carolina.

        Members: Guthrie Birkhead, MD, Albany, New York; Karen Broder, MD, Atlanta, Georgia; Dennis Brooks, MD, Baltimore, Maryland; Angela Calugar, MD, Atlanta, Georgia; Richard Clover, MD, Louisville, Kentucky; James Cheek, MD, Albuquerque, New Mexico; Margaret Cortese, MD, Atlanta, Georgia; Shelly Deeks, MD, Toronto, Ontario, Canada; Lorraine Duncan, Portland, Oregon; Geoffrey Evans, MD, Rockville, Maryland; Theresa Finn, PhD, Rockville, Maryland; Stanley Gall, MD, Louisville, Kentucky; Steve Gordon, MD, Cleveland, Ohio; Janet Gilsdorf, MD, Ann Arbor, Michigan; John Iskander, MD, Atlanta, Georgia; David Klein, PhD, Bethesda, Maryland; Katrina Kretsinger, MD, Atlanta, Georgia; Susan Lett, MD, Boston, Massachusetts; Sara Long, MD, Philadelphia, Pennsylvania; Bruce Meade, PhD, Rockville, Maryland; Julie Morita, MD, Chicago, Illinois; Trudy Murphy, MD, Atlanta, Georgia; Stephen Phillips, DO, Falls Church, Virginia; Margaret Rennels, MD, Baltimore, Maryland; Robert Scalettar, MD, North Haven, Connecticut; William Schaffner, MD, Nashville, Tennessee; Ann Schwartz, MD, Rockville Maryland; Barbara Slade, MD, Atlanta, Georgia; Tejpratap Tiwari, MD, Atlanta, Georgia; Gregory Wallace, MD, Atlanta, Georgia.

        Advisory Committee on Immunization Practices
        Membership List, June 2005

        Chairman: Myron J. Levin, MD, University of Colorado Health Sciences Center, Denver, Colorado.

        Executive Secretary: Larry K. Pickering, MD, Senior Advisor to the Director, National Immunization Program, CDC, Atlanta, Georgia.

        Members: Jon S. Abramson, MD, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Ban Mishu Allos, MD, Vanderbilt University School of Medicine, Nashville, Tennessee; Guthrie S. Birkhead, MD, New York State Department of Health, Albany, New York; Judith Campbell, MD, Baylor College of Medicine, Houston, Texas; Reginald Finger, MD, Focus on the Family, Colorado Springs, Colorado; Janet R. Gilsdorf, MD, University of Michigan, Ann Arbor, Michigan; Tracy Lieu, MD, Harvard Pilgram Healthcare and Harvard Medical School, Boston, Massachusetts; Edgar K. Marcuse, MD, Children's Hospital and Regional Medical Center, Seattle, Washington; Julie Morita, MD, Chicago Department of Public Health, Chicago, Illinois; Gregory A. Poland, MD, Mayo Medical School, Rochester, Minnesota; John B. Salamone, National Italian American Foundation, Washington, D.C.; Patricia, Stinchfield, MS, Children's Hospitals and Clinics, St. Paul, Minnesota; John J. Treanor, MD, University of Rochester School of Medicine and Dentistry, Rochester, New York; and Robin J. Womeodu, MD, University of Tennessee Health Sciences Center, Memphis, Tennessee.

        Ex-Officio Members: James E. Cheek, MD, Indian Health Service, Albuquerque, New Mexico; Wayne Hachey, DO, Department of Defense, Falls Church, Virginia; Geoffrey S. Evans, MD, Health Resources and Services Administration, Rockville, Maryland; Bruce Gellin, MD, National Vaccine Program Office, Washington, DC; Linda Murphy, Centers for Medicare and Medicaid Services, Baltimore, Maryland; George T. Curlin, MD, National Institutes of Health, Bethesda, Maryland; Norman Baylor, PhD, Office of Vaccines Research Review, Rockville, Maryland; Kristin Lee Nichol, MD, Department of Veterans Affairs, Minneapolis, Minnesota.

        Liaison Representatives: Jonathan Temte, MD, Madison, Wisconsin, Richard D. Clover, MD, Louisville, Kentucky, American Academy of Family Physicians; Margaret Rennels, MD, Baltimore, Maryland, Carol Baker, MD, Houston, Texas, American Academy of Pediatrics; Andrea Gelzer, MD, Hartford, Connecticut, America's Health Insurance Plans; James C. Turner, MD, Charlottesville, Virginia, American College Health Association; Stanley Gall, MD, Louisville, Kentucky, American College of Obstetricians and Gynecologists; Kathleen M. Neuzil, MD, Seattle, Washington, American College of Physicians; Litjen Tan, PhD, Chicago, Illinois, American Medical Association; Stephan L. Foster, PharmD, Memphis, Tennessee, American Pharmacists Association; W. Paul McKinney, MD, Louisville, Kentucky, Association of Teachers of Preventive Medicine; Clement Lewin, PhD, Orange, Connecticut, Biotechnology Industry Organization; Monika Naus, MD, Vancouver, British Columbia, Canada, Canadian National Advisory Committee on Immunization; Steve Gordon, MD, Cleveland, Ohio, Healthcare Infection Control Practices Advisory Committee, Samuel L. Katz, MD, Durham, North Carolina, and William Schaffner, MD, Nashville, Tennessee, Infectious Diseases Society of America; David M. Salisbury, MD, London, United Kingdom, London Department of Health; Nancy Bennett, MD, Rochester, New York, National Association of County and City Health Officials; David A. Neumann, PhD, Alexandria, Virginia, National Coalition for Adult Immunization; Romeo Rodriguez, Mexico City, Mexico, National Immunization Council and Child Health Program; Dennis A. Brooks, MD, Baltimore, Maryland, National Medical Association; Charles Helms, MD, Iowa City, Iowa, National Vaccine Advisory Committee; Amy B. Middleman, MD, Houston, Texas, Society for Adolescent Medicine; Damian A. Braga, MBA, Swiftwater, Pennsylvania, Peter Paradiso, PhD, Collegeville, Pennsylvania, Pharmaceutical Research and Manufacturers of America.

        Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
         

        Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.


        References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

        Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

        **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

        Date last reviewed: 3/9/2006

        HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
        POLICY  |  DISCLAIMER  |  ACCESSIBILITY

        Safer, Healthier People

        Morbidity and Mortality Weekly Report
        Centers for Disease Control and Prevention
        1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

        USA.GovDHHS

        Department of Health
        and Human Services




        国产精品久久久久久一级毛片